PACAMUS
Pituitary adenylate cyclase activating polypeptide in stressed patients with Multiple sclerosis (MS) or clinically isolated syndrome suggestive for MS under treatment with glatiramer acetate (PACAMUS) - a randomized controlled trial
What it found
No result found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Glatiramer acetate
Unknown
What it measured
Main measures
- changes in VIP/PACAP serum concentration
How the body handles the medicine
Who could take part
Early (CIS/RIS)
Inclusion: - informed consent Exclusion: - patient younger than 18 or older than 60 years old
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
- changes in VIP/PACAP serum concentrations
Loading reviews and guidelines…
Related trials
- PreCISe
Phase 3 · Completed
Met its main goal
History
Started
Feb 2010
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error